http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101401159-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2006-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101401159-B1 |
| titleOfInvention | Antibodies to amyloid beta with glycosylation at variable sites |
| abstract | The present invention relates to a purified antibody molecule, Wherein at least one antigen binding site comprises glycosylated asparagine (Asn) at a variable region of the heavy chain (V H ), more particularly the pharmaceutical and diagnostic compositions comprising said antibody molecule and antibody mixture comprise a beta-A4 peptide / (V H ) & lt ; / RTI & gt ; of an antibody mixture comprising one or two glycosylated antigen binding sites with glycosylated asparagine (Asn) in the variable region of the heavy chain, A mixture of antibody isomers comprising a glycosylated Asn at a variable site, and also a specific glycosylated antibody isomer, and further relates to the pharmaceutical and diagnostic uses for said antibody, wherein said antibody The isomer is characterized, for example, in that it can be used for pharmaceutical prophylaxis and / or diagnosis of amyloid formation or amyloid-plaque formation The. |
| priorityDate | 2005-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 480.